DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Bilirubin Meter Market

Global Bilirubin Meter Market Opportunities and Forecast 2020-2027

  • DLR2685
  • 25 July, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Bilirubin Meter Market, By Product (Transcutaneous Devices, Benchtop), By Indication (Hepatitis, Jaundice, Others), By Age Group (Neonates, Adult), By End-Users (Hospitals, Clinics, Others), and opportunities and forecast 2020-2027

Bilirubin Meter Market Overview

Bilirubin meters are prominently used to measure the concentration of bilirubin in serum and blood. Bilirubin, formerly known as haematoidin, is a yellow substance that is found in the normal catabolic pathway of vertebrates. Low bilirubin is directly connected to the indications of metabolic syndrome, diabetes, and cardiovascular conditions, and high bilirubin concentration is linked to hemolysis conditions, hepatitis, jaundice, and the probability of bile ducts.

The global Bilirubin Meter market is projected to rise at a significant rate in the forecast period. The increasing prevalence of jaundice, hepatitis, and other chronic diseases mainly boost the growth of the market. The rise in cases of jaundice and hepatitis particularly in neonates increases the demand for effective diagnosis of neonatal jaundice, which acts as the major factor to enlarge the growth of the Bilirubin Meter market. In addition, accuracy offered by the bilirubin meters in disease diagnosis is expected to fuel the growth of the bilirubin meters market during the forecast period. As well, technological advancements in devices overcome inconsistencies in total serum bilirubin measurement and the rise in demand for portable diagnostic devices are remarkably contributes to the growth of the Bilirubin Meter market.

On the downside, lack of product awareness and poor product availability in developing countries are expected to hamper the growth of the market during the forecast period.

Covid-19 Impact on Bilirubin Meter Market:

In addition, the current Bilirubin Meter Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Bilirubin Meter Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Bilirubin Meter Market Segment Overview

Based on Product, the Transcutaneous Devices segment has the largest share in the market. This is because these devices are accurate, cost-effective, time-saving, and non-invasive. These devices are used as an alternative for serum bilirubin analyzers as they are capable to screen jaundice in neonates without the requirement for a needle prick. In addition to this, according to the National Institute of Health (NIH) in 2019, neonatal hyperbilirubinemia was a leading cause of hospitalization, an estimate of 60-80% of newborn babies were affected by this condition. This factor driving the transcutaneous bilirubin meters for screening infants. Based on Indication, the jaundice segment dominated the market as it held the largest market share in 2019. Jaundice is most prevalent in the USA, where approximately 60% of newborns are affected by it.

Bilirubin Meter Market, By Product

·       Transcutaneous Devices
·       Benchtop

Bilirubin Meter Market, By Indication

·       Hepatitis
·       Jaundice
·       Others

Bilirubin Meter Market, By Age Group

·       Neonates
·       Adult

Bilirubin Meter Market, By End-Users

·       Hospitals
·       Clinics
·       Others

Bilirubin Meter Market Regional Overview

In terms of region, North America held a significant market share in 2019 and is expected to continue its dominance during the forecast period. This is due to the increasing incidence of jaundice in neonates in this region. Along with this, other factors like increasing healthcare expenditure and well-established healthcare infrastructure boost the market growth in North America. Similarly, Asia Pacific is expected to witness remarkable growth in the forecast period. Factors such as developing healthcare infrastructure and rising healthcare expenditures in this region.

Bilirubin Meter Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Bilirubin Meter Market, Key Players

·       F. Hoffmann-La Roche Ltd.
·       Koninklijke Philips N.V.
·       Shenzhen Mindray Bio-Medical Electronics Co., Ltd
·       Siemens Healthineers AG
·       Drägerwerk AG & Co. KGaA
·       Zhengzhou Dison Instrument And Meter Co., Ltd
·       Mennen Medical Ltd.
·       Natus Medical Incorporated
·       Ningbo David Medical Device Co., Ltd
·       Micro Lab Instruments, APEL Co., Ltd.
·       Avihealthcare

Bilirubin Meter Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Bilirubin Meter Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Product
        • 5.2.1. Transcutaneous Devices
        • 5.2.2. Benchtop
      • 5.3. Market Analysis, Insights and Forecast – By Indication
        • 5.3.1. Hepatitis
        • 5.3.2. Jaundice
        • 5.3.3. Others
      • 5.4. Market Analysis, Insights and Forecast – By Age Group
        • 5.4.1. Neonates
        • 5.4.2. Adult
      • 5.5. Market Analysis, Insights and Forecast – By End-Users
        • 5.5.1. Hospitals
        • 5.5.2. Clinics
        • 5.5.3. Others
      • 5.6. Market Analysis, Insights and Forecast – By Region
        • 5.6.1. North America
        • 5.6.2. Europe
        • 5.6.3. Asia Pacific
        • 5.6.4. Latin America, Middle East and Africa

      6. North America Bilirubin Meter Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Product
        • 6.2.1. Transcutaneous Devices
        • 6.2.2. Benchtop
      • 6.3. Market Analysis, Insights and Forecast – By Indication
        • 6.3.1. Hepatitis
        • 6.3.2. Jaundice
        • 6.3.3. Others
      • 6.4. Market Analysis, Insights and Forecast – By Age Group
        • 6.4.1. Neonates
        • 6.4.2. Adult
      • 6.5. Market Analysis, Insights and Forecast – By End-Users
        • 6.5.1. Hospitals
        • 6.5.2. Clinics
        • 6.5.3. Others
      • 6.6. Market Analysis, Insights and Forecast – By Country
        • 6.6.1. U.S.
        • 6.6.2. Canada

      7. Europe Bilirubin Meter Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Product
        • 7.2.1. Transcutaneous Devices
        • 7.2.2. Benchtop
      • 7.3. Market Analysis, Insights and Forecast – By Indication
        • 7.3.1. Hepatitis
        • 7.3.2. Jaundice
        • 7.3.3. Others
      • 7.4. Market Analysis, Insights and Forecast – By Age Group
        • 7.4.1. Neonates
        • 7.4.2. Adult
      • 7.5. Market Analysis, Insights and Forecast – By End-Users
        • 7.5.1. Hospitals
        • 7.5.2. Clinics
        • 7.5.3. Others
      • 7.6. Market Analysis, Insights and Forecast – By Country
        • 7.6.1. UK
        • 7.6.2. Germany
        • 7.6.3. France
        • 7.6.4. Italy
        • 7.6.5. Spain
        • 7.6.6. Russia
        • 7.6.7. Rest of Europe

      8. Asia Pacific Bilirubin Meter Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Product
        • 8.2.1. Transcutaneous Devices
        • 8.2.2. Benchtop
      • 8.3. Market Analysis, Insights and Forecast – By Indication
        • 8.3.1. Hepatitis
        • 8.3.2. Jaundice
        • 8.3.3. Others
      • 8.4. Market Analysis, Insights and Forecast – By Age Group
        • 8.4.1. Neonates
        • 8.4.2. Adult
      • 8.5. Market Analysis, Insights and Forecast – By End-Users
        • 8.5.1. Hospitals
        • 8.5.2. Clinics
        • 8.5.3. Others
      • 8.6. Market Analysis, Insights and Forecast – By Country
        • 8.6.1. China
        • 8.6.2. India
        • 8.6.3. Japan
        • 8.6.4. Australia
        • 8.6.5. South East Asia
        • 8.6.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Bilirubin Meter Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Product
        • 9.2.1. Transcutaneous Devices
        • 9.2.2. Benchtop
      • 9.3. Market Analysis, Insights and Forecast – By Indication
        • 9.3.1. Hepatitis
        • 9.3.2. Jaundice
        • 9.3.3. Others
      • 9.4. Market Analysis, Insights and Forecast – By Age Group
        • 9.4.1. Neonates
        • 9.4.2. Adult
      • 9.5. Market Analysis, Insights and Forecast – By End-Users
        • 9.5.1. Hospitals
        • 9.5.2. Clinics
        • 9.5.3. Others
      • 9.6. Market Analysis, Insights and Forecast – By Country
        • 9.6.1. Brazil
        • 9.6.2. Saudi Arabia
        • 9.6.3. UAE
        • 9.6.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. F. Hoffmann-La Roche Ltd.
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Koninklijke Philips N.V.
      • 10.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
      • 10.7. Siemens Healthineers AG
      • 10.8. Drägerwerk AG & Co. KGaA
      • 10.9. Zhengzhou Dison Instrument And Meter Co., Ltd
      • 10.10. Mennen Medical Ltd.
      • 10.11. Natus Medical Incorporated
      • 10.12. Ningbo David Medical Device Co., Ltd
      • 10.13. Micro Lab Instruments, APEL Co., Ltd.

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934